| Rights | Preview | Issue Date | Title | Author(s) | Type |
| closedAccess |  | 2016 | C-Jun N-terminal kinase inactivation by mitogen-activated protein kinase phosphatase 1 determines resistance to taxanes and anthracyclines in breast cancer | Rincón, Raúl; Zazo, Sandra; Manso, Rebeca CSIC; Perona Abellón, Rosario CSIC ORCID; Albanell, Joan; Madoz-Gúrpide, Juan CSIC; Rojo, Federico | artículo |
| closedAccess |  | Feb-2020 | Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients | Cortés, Javier; Ciruelos, Eva María; Pérez-García, José Manuel; Albanell, Joan; García-Estévez, Laura; Ruiz-Borrego, Manuel; Espinosa, Ruth; Gallegos, Isabel; González, Santiago; Álvarez, Isabel; Llombart, Antonio | artículo de revisión |
| closedAccess |  | 2017 | Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer | Sabbaghi, Mohammad A.; Gil-Gómez, Gabriel; Guardia, Cristina; Servitja, Sonia; Arpí, Oriol; García-Alonso, Sara; Menendez, Silvia; Arumi-Uria, Montserrat; Serrano, Laia; Salido, Marta; Muntasell, Aura; Martínez-García, Maria; Zazo, Sandra; Chamizo, Crsitina; Gonzalez-Alonso, Paula; Madoz-Gúrpide, Juan CSIC; Eroles, Pilar; Arribas, Joaquín; Tusquets, Ignasi; Lluch, Ana; Pandiella, Atanasio CSIC ORCID CVN ; Rojo, Federico; Rovira, Ana; Albanell, Joan | artículo |
| openAccess |  | 23-Apr-2019 | Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities | Martínez-Bosch, Neus CSIC ORCID CVN; Rodriguez-Vida, Alejo; Juanpere, Núria; Lloreta, Josep; Rovira, Ana; Albanell, Joan; Bellmunt, Joaquim; Navarro Medrano, Pilar CSIC ORCID | artículo |
| openAccess |  | 2007 | Inhibition of the canonical IKK/NFκB pathway sensitizes human cancer cells to doxorubicin | Rodriguez-Fanjul, V. CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Albanell, Joan | artículo |
| closedAccess |  | 2009 | Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin | Cortés-Sempere, María CSIC; Rodriguez-Fanjul, V. CSIC ORCID; Sánchez-Pérez, Isabel CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Albanell, Joan | artículo |
| closedAccess |  | 2009 | MKP1 repression is required for the chemosensitizing effects of NF-κB and PI3K inhibitors to cisplatin in non-small cell lung cancer | Cortés-Sempere, María CSIC; Rodriguez-Fanjul, V. CSIC ORCID; Belda-Iniesta, Cristobal; Cejas, Paloma; Machado-Pinilla, R. CSIC; Manguan-García, Cristina CSIC; Sánchez-Pérez, Isabel CSIC ORCID; Nistal, Manuel; Moratilla, Carmen CSIC; Castro Carpeño, Javier de; González Barón, Manuel; Albanell, Joan; Perona Abellón, Rosario CSIC ORCID | artículo |
| closedAccess |  | Jul-2022 | mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer | Casadevall, David; Hernández-Prat, Anna; García-Alonso, Sara; Menendez, Silvia; Qin, Mengjuan; Guardia, Cristina; Morancho, B.; Sánchez-Martín, Francisco Javier; Zazo, Sandra; Gavilán, Elena CSIC ORCID; Sabbaghi, Mohammad A.; Eroles, Pilar; Cejalvo, Juan Miguel; Lluch, Ana; Rojo, Federico; Pandiella, Atanasio CSIC ORCID CVN ; Rovira, Ana; Albanell, Joan | artículo |
| closedAccess |  | 15-Sep-2021 | Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer | Guardia, Cristina; Bianchini, Giampaolo; Arpí, Oriol; Menendez, Silvia; Casadevall, David; Galbardi, Barbara; Dugo, Matteo; Servitja, Sonia; Montero, Juan Carlos CSIC ORCID CVN; Soria-Jiménez, Luis; Sabbaghi, Mohammad A.; Peña, Raúl; Madoz-Gúrpide, Juan CSIC; Lloveras, Belén; Lluch, Ana; Eroles, Pilar; Arribas, Joaquín; Pandiella, Atanasio CSIC ORCID CVN ; Gianni, Luca; Rojo, Federico; Rovira, Ana; Albanell, Joan | artículo |
